Literature DB >> 33622916

Association of the Modified ALBI Grade With Endoscopic Findings of Gastroesophageal Varices.

Yuho Miyamoto1,2, Hirayuki Enomoto3, Hiroki Nishikawa1, Takashi Nishimura1, Yoshinori Iwata1, Shuhei Nishiguchi4, Hiroko Iijima1.   

Abstract

BACKGROUND/AIM: This study aimed to assess the association of the modified albumin-bilirubin (mALBI) grade with the endoscopic findings of gastroesophageal varices (GEVs). PATIENTS AND METHODS: A total of 141 patients with histologically proven cirrhosis who underwent a liver biopsy and esophagogastroduodenoscopy were enrolled. The relationships between the mALBI grade and endoscopic findings were evaluated.
RESULTS: The incidence of GEVs and high-risk GEVs differed among mALBI grades. Patients with mALBI grades of 2b-3 had higher rates of GEVs and high-risk GEVs in comparison to those with mALBI grades of 1-2a (p<0.0001). In addition, patients with mALBI grade 2b or grade 3, but not those with mALBI grade 2a, had significantly higher rates of complicated GEVs and high-risk GEVs in comparison to those with mALBI grade 1.
CONCLUSION: The mALBI grade may be useful in predicting the presence of GEVs and for stratifying their bleeding risk. Copyright
© 2021, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  ALBI score; Liver cirrhosis; gastroesophageal varices

Year:  2021        PMID: 33622916      PMCID: PMC8045113          DOI: 10.21873/invivo.12364

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  17 in total

1.  Arm Skeletal Muscle Mass Is Associated With the Prognosis of Patients With Cirrhosis.

Authors:  Yoshihiro Shimono; Hirayuki Enomoto; Kyohei Kishino; Ei-Ichiro Moriwaki; Hiroki Nishikawa; Takashi Nishimura; Yoshinori Iwata; Hiroko Iijima; Shuhei Nishiguchi
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

2.  Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension.

Authors:  Roberto de Franchis
Journal:  J Hepatol       Date:  2015-06-03       Impact factor: 25.083

Review 3.  Evidence-based clinical practice guidelines for liver cirrhosis 2015.

Authors:  Hiroshi Fukui; Hidetsugu Saito; Yoshiyuki Ueno; Hirofumi Uto; Katsutoshi Obara; Isao Sakaida; Akitaka Shibuya; Masataka Seike; Sumiko Nagoshi; Makoto Segawa; Hirohito Tsubouchi; Hisataka Moriwaki; Akinobu Kato; Etsuko Hashimoto; Kojiro Michitaka; Toshikazu Murawaki; Kentaro Sugano; Mamoru Watanabe; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2016-05-31       Impact factor: 7.527

4.  Prediction of the varices needing treatment with non-invasive tests in patients with compensated advanced chronic liver disease.

Authors:  Han Ah Lee; Seung Up Kim; Yeon Seok Seo; Young-Sun Lee; Seong Hee Kang; Young Kul Jung; Moon Young Kim; Ji Hoon Kim; Sang Gyune Kim; Ki Tae Suk; Soung Won Jung; Jae Young Jang; Hyonggin An; Hyung Joon Yim; Soon Ho Um
Journal:  Liver Int       Date:  2019-02-06       Impact factor: 5.828

Review 5.  The noninvasive diagnosis of esophageal varices and its application in clinical practice.

Authors:  Etienne Pateu; Frédéric Oberti; Paul Calès
Journal:  Clin Res Hepatol Gastroenterol       Date:  2017-09-01       Impact factor: 2.947

6.  The Anthropometric Assessment With the Bioimpedance Method Is Associated With the Prognosis of Cirrhotic Patients.

Authors:  Ei-Ichiro Moriwaki; Hirayuki Enomoto; Masaki Saito; Naoki Hara; Hiroki Nishikawa; Takashi Nishimura; Yoshinori Iwata; Hiroko Iijima; Shuhei Nishiguchi
Journal:  In Vivo       Date:  2020 Mar-Apr       Impact factor: 2.155

7.  Validation of Modified ALBI Grade for More Detailed Assessment of Hepatic Function in Hepatocellular Carcinoma Patients: A Multicenter Analysis.

Authors:  Atsushi Hiraoka; Takashi Kumada; Kunihiko Tsuji; Koichi Takaguchi; Ei Itobayashi; Kazuya Kariyama; Hironori Ochi; Kazuto Tajiri; Masashi Hirooka; Noritomo Shimada; Toru Ishikawa; Yoshihiko Tachi; Toshifumi Tada; Hidenori Toyoda; Kazuhiro Nouso; Kouji Joko; Yoichi Hiasa; Kojiro Michitaka; Masatoshi Kudo
Journal:  Liver Cancer       Date:  2018-06-11       Impact factor: 11.740

8.  Transition in the etiology of liver cirrhosis in Japan: a nationwide survey.

Authors:  Hirayuki Enomoto; Yoshiyuki Ueno; Yoichi Hiasa; Hiroki Nishikawa; Shuhei Hige; Yasuhiro Takikawa; Makiko Taniai; Toru Ishikawa; Kohichiroh Yasui; Akinobu Takaki; Koichi Takaguchi; Akio Ido; Masayuki Kurosaki; Tatsuya Kanto; Shuhei Nishiguchi
Journal:  J Gastroenterol       Date:  2019-11-25       Impact factor: 7.527

9.  Impact of Sustained Virological Response for Gastroesophageal Varices in Hepatitis-C-Virus-Related Liver Cirrhosis.

Authors:  Yukihisa Yuri; Hiroki Nishikawa; Hirayuki Enomoto; Kazunori Yoh; Yoshinori Iwata; Yoshiyuki Sakai; Kyohei Kishino; Naoto Ikeda; Tomoyuki Takashima; Nobuhiro Aizawa; Ryo Takata; Kunihiro Hasegawa; Noriko Ishii; Takashi Nishimura; Hiroko Iijima; Shuhei Nishiguchi
Journal:  J Clin Med       Date:  2019-12-30       Impact factor: 4.241

View more
  2 in total

1.  Modification of the ALBI-PLT Score for the Prediction of High-risk Varices.

Authors:  Minako Inoue-Yuri; Hirayuki Enomoto; Ichiro Wakabayashi; Yukihisa Yuri; Nobuhiro Aizawa; Naoto Ikeda; Tomoyuki Takashima; Aoi Fujiwara; Ryota Yoshioka; Shoki Kawata; Kohei Yoshihara; Shogo Ota; Ryota Nakano; Hideyuki Shiomi; Takashi Nishimura; Shuhei Nishiguchi; Hiroko Iijima
Journal:  In Vivo       Date:  2022 May-Jun       Impact factor: 2.406

Review 2.  The ALBI score: From liver function in patients with HCC to a general measure of liver function.

Authors:  Hidenori Toyoda; Philip J Johnson
Journal:  JHEP Rep       Date:  2022-08-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.